Setback for EU votes on joint reclassification and nomenclature
This article was originally published in Clinica
Voting on the European Commission's Directive on the reclassification of joint implants has been delayed. The April 29 deadline for voting by the Article 7 committee, which votes on issues relating to the implementation of the medical device directives, has been cancelled due to the translations of the Directive not all being available.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.